Scribe Therapeutics (SCTX) IPO deck
Scribe Therapeutics is a biotechnology company focused on the production and development of in vivo CRISPR gene-silencing therapies for cardiometabolic diseases.
Scribe Therapeutics is a biotechnology company focused on the production and development of in vivo CRISPR gene-silencing therapies for cardiometabolic diseases.
%20IPO%20deck){kind=link}